MDX-447 shows promising biological activity in phase I/II trial, results reported at ASCO meeting May 25, 1999
News from ASCO: phase I trial of PNU-214565 dose escalation tied to baseline anti-SEA antibodies May 21, 1999
Cantab in-licenses Novasomes adjuvant for use in TA-CIN vaccine; clinical testing in sight April 26, 1999
RSS